Latest News & Features
article
Pharmaceutical company Mallinckrodt has filed a complaint against Mylan for alleged patent infringement over its drug Ofirmev, a treatment for fever. 2 December 2016
Americas
Merck has filed a complaint against Strides Pharma for alleged patent infringement over Sustiva, an antiviral medication that prevents HIV from multiplying in the human body. 1 December 2016
Americas
An interference proceeding on the patent rights to CRISPR/Cas9 will take place on December 6, with the judges setting the definition of the disputed invention as “the use of CRISPR in a method in a eukaryotic cell”. 1 December 2016
Europe
Law firm HGF has hired a new patent director, Martin Connors, who will start tomorrow. 30 November 2016
Americas
A US district court has dismissed a patent infringement lawsuit between US-based biotechnology company Genzyme and Mylan Pharmaceuticals after the companies agreed to settle. 30 November 2016
Big Pharma
UK life sciences organisations are still uncertain about the implications of Britain’s departure from the EU, despite welcoming the announcement that the UK will ratify the Unified Patent Court Agreement. 30 November 2016
Americas
Nevro, a US-based medical device company, filed a complaint against Boston Scientific yesterday in a US district court for allegedly infringing patents covering Nevro’s spinal cord stimulation therapy. 29 November 2016
Africa
Mylan has entered into a sub-licensing agreement with the Medicines Patent Pool, a UN-backed public health organisation, to expand access to chronic hepatitis C medicines in developing countries. 29 November 2016
Big Pharma
The market for counterfeit pharmaceuticals is worth $200 billion a year, beating almost everything else in the underground economy, including prostitution, human trafficking and illegal arms sales. 28 November 2016
Big Pharma
The English High Court has ruled in favour of Merck Sharp & Dohme (MSD) in a patent battle against Shionogi, over Merck’s product Isentress. 28 November 2016